Search hospitals > Hawaii > Honolulu
University of Hawaii Cancer Center
Claim this profileHonolulu, Hawaii 96813
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Recurrence
Conducts research for Lung Cancer
Conducts research for Tumors
313 reported clinical trials
11 medical researchers
Summary
University of Hawaii Cancer Center is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Lung Cancer, Tumors and other specialties. University of Hawaii Cancer Center is involved with conducting 313 clinical trials across 503 conditions. There are 11 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Michael Carney, MD, and Jami A. Fukui.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
Jeffrey L. BerenbergStraub Clinic and Hospital7 years of reported clinical research
Expert in Lung Cancer
Expert in Cancer
28 reported clinical trials
75 drugs studied
Jared D. AcobaQueen's Medical Center4 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
15 reported clinical trials
35 drugs studied
Michael Carney, MDKapiolani Medical Center for Women and Children4 years of reported clinical research
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
14 reported clinical trials
29 drugs studied
Jami A. FukuiKapiolani Medical Center for Women and Children5 years of reported clinical research
Studies Breast Cancer
Studies Cancer
14 reported clinical trials
35 drugs studied
Clinical Trials running at University of Hawaii Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Bladder Cancer
Tumors
Ovarian Cancer
Fallopian Tube Cancer
Squamous Cell Carcinoma
Lung Carcinoma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Hawaii Cancer Center?
University of Hawaii Cancer Center is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Lung Cancer, Tumors and other specialties. University of Hawaii Cancer Center is involved with conducting 313 clinical trials across 503 conditions. There are 11 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Michael Carney, MD, and Jami A. Fukui.
Where is University of Hawaii Cancer Center located?
The University of Hawaii Cancer Center is located at 701 Ilalo Street, Suite 600, Honolulu, HI 96813.
Who should I call to ask about financial aid or insurance network?
**University of Hawaii Cancer Center Contact Information:**
- General Inquiries: (808) 586-3010, Email: [email protected]
- Patient-Related Matters: Phone: (808) 586-5854, Fax: (808) 586-5857
**Hawaii Society of Clinical Oncology (HSCO):**
- Offers financial advocacy and patient assistance resources.
**UHA Health Insurance:**
- Customer Service: (808) 532-4000, Toll-Free: (800) 458-4600
What insurance does University of Hawaii Cancer Center accept?
The University of Hawaii Cancer Center accepts the UH Student Plan (HMSA), providing comprehensive coverage for students enrolled in the University of Hawaii system who meet the credit requirement. This plan is widely accepted across Hawaii and offers medical, prescription drug, laboratory, radiology, mental health, family planning, medical evacuation, and overseas travel benefits. Additional benefits such as Dental, Repatriation, Life Insurance, and Accidental Death & Dismemberment can be purchased separately.
What awards or recognition has University of Hawaii Cancer Center received?
The University of Hawaii Cancer Center, designated by the National Cancer Institute (NCI) since 1996, specializes in cutting-edge cancer research, focusing on the diverse populations in Hawaii and the Pacific. It has received continuous NCI funding for the Multiethnic Cohort (MEC) Study, tracking over 215,000 residents of Hawaii and Los Angeles for cancer and chronic disease development. This recognition enables the center to secure an average of $40 million annually in grants.